Invivyd, Inc. (IVVD) intrinsic value & 10-year financials

Invivyd, Inc. (IVVD) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 7 fiscal years revenue grew 110.5% a year to $53.4M, with an average return on invested capital of -222.1%.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$0.62
Market cap
$106.5M
Revenue (FY2025)
$53.4M
Revenue growth (7-yr CAGR)
110.5%
ROIC (10-yr avg)
-222.1%
Free cash flow (FY2025)
-$58.3M

IVVD 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $53.4M -$52.5M -$0.30 -$58.3M -104.0% -781.4%
FY2024 $25.4M -$169.9M -$1.43 -$170.6M -696.8% 1458.1%
FY2023 $0 -$198.6M -$1.81 -$173.8M — -174.7%
FY2022 — -$241.3M -$2.23 -$221.7M — -176.0%
FY2021 — -$226.8M -$5.32 -$184.8M — -1436.6%
FY2020 — — — — — —
FY2016 — — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Invivyd, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

Invivyd, Inc. has historically struggled to out-earn its cost of capital, averaging just -2.2% ROIC.

Invivyd, Inc. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Invivyd, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-9.96 per share.

IVVD stock: frequently asked questions

What is the intrinsic value of Invivyd, Inc. (IVVD) stock?

Graham's formula only works with positive earnings. Invivyd, Inc. reported diluted EPS of -$0.30 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

Does Invivyd, Inc. generate free cash flow?

Invivyd, Inc. generated -$58.3M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 0 of the last 5 reported years.

What is IVVD's return on invested capital?

Average ROIC over the last 7 fiscal years was -222.1%, and average return on equity was -78.4%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this IVVD data come from?

From Invivyd, Inc.'s annual 10-K filings on SEC EDGAR, most recently filed May 14, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar biological products stocks